(Q69374795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

S B Ross

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

D M Jackson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 July 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

1 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

13-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2571943%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00169200

1 October 2019

exact match

0 references

cites work

Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine

1 reference

12 December 2020

Comparison of the dopaminergic effects of apomorphine and (−)-N-n-propylnorapomorphine

1 reference

12 December 2020

Relationship between receptor occupancy and response at striatal dopamine autoreceptors

1 reference

12 December 2020

Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity

1 reference

12 December 2020

Dopamine D2 receptor binding sites for agonists. A tetrahedral model

1 reference

12 December 2020

Detecting behaviorally relevant changes in extracellular dopamine with microdialysis

1 reference

12 December 2020

In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.

1 reference

12 December 2020

3H-N-n-propylnorapomorphine: A novel agonist ligand for central dopamine receptors

1 reference

12 December 2020

Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists

1 reference

12 December 2020

The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.

1 reference

12 December 2020

Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors

1 reference

12 December 2020

Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum

1 reference

12 December 2020

The central stimulatory action of inhibitors of the dopamine uptake

1 reference

12 December 2020

Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.

1 reference

12 December 2020

DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.

1 reference

12 December 2020

Dopamine receptors in brain and periphery

1 reference

12 December 2020

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

12 December 2020

Differential labelling of dopamine receptors in rat brain in vivo: Comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine

1 reference

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

12 December 2020

Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo.

1 reference

12 December 2020

Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo

1 reference

12 December 2020

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.

1 reference

12 December 2020

Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?

1 reference

12 December 2020

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

1 reference

12 December 2020

Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat

1 reference

12 December 2020

In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism

1 reference

12 December 2020

Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry

1 reference

12 December 2020

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020